If you experience any suspected side effects from your medications, you can report them through the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk or via the Yellow Card app)
Why weight-loss drugs became more popular than ever this year Demand for powerful new medications for obesity and diabetes probably wont let up This year, celebrity gossip, a national shortage and eyebrow-raising clinical trials made household names of weight-loss and diabetes drugs like Ozempic, Wegovy and Mounjaro
The reason is weight loss, and its impact on one sleep disorder in particular
August 2024 : Positive Phase 3 trial results for oral semaglutide were announced, enhancing patient adherence and convenience, strengthening Eli Lillys position in type 2 diabetes and obesity management markets
If you have kidney disease, make sure to discuss this with your healthcare provider